GMPs Send Smaller Supplement Firms Into Contract Manufacturers’ Arms
This article was originally published in The Tan Sheet
Executive Summary
FDA enforcement of the good manufacturing practices final rule causes some in the supplement industry to question whether small and medium-sized firms can manufacture in-house successfully. Meanwhile, third-party manufacturers are realizing the benefits of a tighter regulatory environment.
You may also be interested in...
FDA Will Peel Back Another Layer Of GMP Compliance In 2013
FDA will take GMP inspections beyond the basics in 2013, experts agree. Firms can expect more inspections, deeper dives from reviewers and tougher consequences.
FDA Will Peel Back Another Layer Of GMP Compliance In 2013
FDA will take GMP inspections beyond the basics in 2013, experts agree. Firms can expect more inspections, deeper dives from reviewers and tougher consequences.
Basic GMP Failures Will Prompt Heightened FDA Scrutiny
FDA supplement programs director Dan Fabricant and food and drug law attorney Marc Ullman reflect on the ongoing struggles of many supplement firms to meet good manufacturing practice standards. “‘I don’t have the resources to comply’ is not an excuse. Then get out of the business,” Ullman says.